USGovernment-News.Com

USGovernment-News.Com

News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
Press release distribution service
Home : U.S. Government News Search Engine                          

Home > U.S. Government News > Marketplace :
Home: United State Government News
Home | News | Submit Press Release |

Actos Lawsuits Continue to Be Filed

(EMAILWIRE.COM, January 28, 2012 ) New York, NY – Actos lawsuits continue to be filed on behalf of users who developed bladder cancer, with a recent complaint filed by an Edwardsville man who says he was diagnosed with bladder cancer in June 2010 after taking the diabetes medication on a daily basis between 2007 and Sept. 2011. Pending Actos lawsuits are alleging that Takeda Pharmaceutical Co. and Eli Lilly & Co. failed to provide adequate warnings and withheld information about the bladder cancer risk. Patients who took this drug and were diagnosed with bladder cancer may still have legal recourse for their disease, though there is a time limit for filing Actos lawsuits. To find out if you are eligible for an Actos lawsuit, visit http://www.classaction.org/actos.html today and complete the free, no obligation case review form.

Reportedly, patients began contacting law firms about filing Actos lawsuits after the FDA announced that use of the drug for longer than a year may be linked to an increased risk of bladder cancer. Results from an on-going, ten-year study of the drug revealed an increased risk in patients with the longest exposure to the drug, and those exposed to the highest cumulative doses. In light of the Actos bladder cancer risk, the FDA recommended that doctors not use the drug in those with active bladder cancer, and prescribe it with caution in patients with a prior history of the disease. It also advised patients to inform their doctors immediately if they develop any signs of bladder cancer such as pain during urination or the urgent need to urinate; pain in the lower abdomen or back; and a blood or red color in the urine.

In light of the Actos bladder cancer warning and pending lawsuits, Class Action.org continues to offer a free case evaluation to any user of the drug who was diagnosed with bladder cancer, or loved ones acting on their behalf. Potentially, patients who file Actos bladder cancer lawsuits may be able to seek compensation for medical bills, lost wages and pain and suffering. To learn more about Actos lawsuits and to receive your free case review, visit Class Action.org today.

About Class Action.org

Class Action.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. Class Action.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit http://www.classaction.org today for a no cost, no obligation case evaluation and information about your consumer rights.

ClassAction.org
Tara Nagel
800-449-1970
pressrelease@lawyercentral.com

Source: EmailWire.com

U.S. Governement News: Politics
  • Presidential Elections
  • Democrates
  • Congress
  • House of Representatives
  • President Obama
  • Republican Party
  • Mitt Romney
  • U.S. Senate
  • U.S. Military
  • U.S. Politics
  • Politics Video Feeds

    U.S. Government Resource Center
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    Governing
    Point of Beginning
    Overall Labor Effectiveness (OLE) Achieving a Highly Effective Workforce

    No credit cards, coupons, or promo codes required. Try it today!

    USGovernment-News.Com is a news service of GroupWeb Media LLC